share_log

4: Statement of changes in beneficial ownership of securities-Officer Gallman Cari

4: Statement of changes in beneficial ownership of securities-Officer Gallman Cari

4:持股变动声明-高管 Gallman Cari
美股sec公告 ·  08/05 18:02
Moomoo AI 已提取核心信息
On August 1, 2024, Cari Gallman, EVP of Corporate Affairs at Bristol-Myers Squibb (BMY), engaged in a transaction involving the company's common stock. Gallman executed a sale of 384 shares at a price of $48.17 per share, resulting in a total transaction value of $18,497.28. This sale was part of a transaction coded 'F', typically indicating a payment of exercise price or tax liability by delivering or withholding securities. Additionally, Gallman acquired 1,061 shares through an exercise or conversion of derivative security, coded 'M', at no cost. Following these transactions, Gallman's direct holdings in Bristol-Myers Squibb common stock amounted to 2,109 shares.
On August 1, 2024, Cari Gallman, EVP of Corporate Affairs at Bristol-Myers Squibb (BMY), engaged in a transaction involving the company's common stock. Gallman executed a sale of 384 shares at a price of $48.17 per share, resulting in a total transaction value of $18,497.28. This sale was part of a transaction coded 'F', typically indicating a payment of exercise price or tax liability by delivering or withholding securities. Additionally, Gallman acquired 1,061 shares through an exercise or conversion of derivative security, coded 'M', at no cost. Following these transactions, Gallman's direct holdings in Bristol-Myers Squibb common stock amounted to 2,109 shares.
2024年8月1日,施贵宝(BMY)公司公共事务执行副总裁Cari Gallman进行了一项涉及公司普通股的交易。Gallman以48.17美元/股的价格出售了384股,交易总价值为18,497.28美元。此次交易是‘F’编码的一部分,通常表示通过提供或扣除证券支付行权价格或税负。此外,Gallman通过行使或转换衍生证券以‘M’编码的方式免费获得了1,061股。在这些交易之后,Gallman在施贵宝普通股中的直接持股为2,109股。
2024年8月1日,施贵宝(BMY)公司公共事务执行副总裁Cari Gallman进行了一项涉及公司普通股的交易。Gallman以48.17美元/股的价格出售了384股,交易总价值为18,497.28美元。此次交易是‘F’编码的一部分,通常表示通过提供或扣除证券支付行权价格或税负。此外,Gallman通过行使或转换衍生证券以‘M’编码的方式免费获得了1,061股。在这些交易之后,Gallman在施贵宝普通股中的直接持股为2,109股。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息